Core Viewpoint - The A-share market is experiencing a significant rise in the 6G concept stocks, with notable gains from several companies, indicating growing investor interest in the 6G technology sector [1] Company Summaries - Guomai Technology has reached the daily limit increase in stock price, reflecting strong market confidence and interest in its potential within the 6G sector [1] - Other companies such as Chuangyuanxin, China Satellite Communications, Zhongjing Electronics, Aoshikang, Benchuan Intelligent, and Shenglu Communication have also seen their stock prices rise, suggesting a broader trend of optimism in the 6G technology market [1]

Core Viewpoint - Guomai Technology (002093.SZ) is experiencing rapid growth in its operating performance, with significant increases in net profit and revenue projected for 2025 [1][2]. Financial Performance - For the first half of 2025, the company expects a net profit between 125 million to 156 million yuan, representing a year-on-year growth of 60.52% to 100.33% [1]. - In 2024, Guomai Technology achieved an annual revenue of 549 million yuan and a net profit of 169 million yuan, marking a year-on-year increase of 61.41% [1]. - The first quarter of 2025 saw a net profit of 91.38 million yuan, up 55.82% year-on-year, with revenue of 118 million yuan, a 2.46% increase [1]. Operational Efficiency - The company has reported a continuous increase in net profit for ten consecutive reporting periods, with growth rates exceeding 35%, and over 50% for the last four periods [1]. - The operating efficiency has improved significantly, with the expense ratio decreasing from 41.54% in 2021 to 12.09% in the first quarter of 2025 [2]. Investment and Financial Management - Investment income has shown consistent growth over four consecutive quarters, with figures of 6.239 million, 8.861 million, 30.4 million, and 16.6 million yuan, reflecting year-on-year increases of 103.22%, 238.7%, 297.33%, and 172.89% respectively [3]. - The company's financial health is improving, with the debt-to-asset ratio decreasing from 18.23% at the end of 2022 to 13.55% by the first quarter of 2025 [3]. Market Performance - As of July 2, the company's stock price was 11.82 yuan per share, with a cumulative increase of over 93% in the past 12 months [3].

Investment Rating - The report maintains a "Buy" rating for the company, with a target price of 11.59 CNY [5]. Core Views - The company is expected to achieve a net profit attributable to shareholders of 1.25-1.56 billion CNY for the first half of 2025, representing a year-on-year growth of 61-100%. The non-recurring net profit is projected to be 0.67-0.88 billion CNY, with a growth of 4-36% [1][2]. - The company's traditional business is showing steady growth, while the AI and elderly care sectors are opening new avenues for development. The management is optimistic about future growth and is increasing investments in high-growth industries [1][2]. - The introduction of AI smart bodies and the Guomai coin aims to create a closed-loop ecosystem for AI-driven elderly care services, aligning with national policies [2]. Summary by Sections Financial Performance - The company forecasts revenue of 718 million CNY for 2025, with a growth rate of 30.7%. The net profit attributable to shareholders is expected to be 244 million CNY, reflecting a growth rate of 44.8% [4][10]. - The earnings per share (EPS) for 2025 is projected at 0.24 CNY, with a price-to-earnings (PE) ratio of 48 [4][10]. Business Strategy - The company is focusing on integrating education and technology, expanding its training scale, and enhancing operational efficiency through its "Guomai University Elderly Care" initiative [1][2]. - The AI smart bodies are designed to meet the full cycle of elderly care needs, transitioning from traditional tools to service executors, thus enhancing user engagement and service delivery [2]. Future Outlook - The projected net profits for 2025-2027 are 2.4 billion CNY, 3.1 billion CNY, and 3.9 billion CNY, respectively, with corresponding PE ratios of 48, 37, and 30 [3][4]. - The company is actively seeking high-quality technology acquisition targets to foster a second growth curve [1][2].

Group 1 - The Ministry of Civil Affairs and the Ministry of Education have jointly issued a notice to enhance the role of social organizations in promoting employment for college graduates, encouraging the development of job positions that utilize graduates' skills [1] - The notice aims to expand service areas in education, healthcare, rescue, and elderly care, providing job and internship opportunities for graduates [1] - Social organizations are encouraged to apply for employment internship bases and innovate community service projects that align with the capabilities of college students [1] Group 2 - The Ministry of Education has released teaching equipment configuration standards for seven subjects in ordinary high schools, aiming to standardize and guide the scientific allocation of teaching equipment across the country [2] - This initiative is part of efforts to accelerate the high-quality development of basic education [2] Group 3 - The Education Examination Institute announced that registration for the 2025 second half of the teacher qualification examination will begin on July 4, with the exam held across 31 provinces [3] - Candidates are required to follow their respective provincial announcements for registration and payment procedures [3] Group 4 - Guomai Technology has projected a net profit of 125 million to 156 million yuan for the first half of 2025, representing a year-on-year growth of 60.52% to 100.33% [5] Group 5 - Dou Shen Education is facing a potential fine of 2.3 million yuan for failing to disclose litigation matters in a timely manner, with the China Securities Regulatory Commission initiating an investigation [6] - The company and its executives are subject to administrative penalties due to non-compliance with information disclosure regulations [6] Group 6 - A new company, Yinchuan Jiuxing Technology Co., Ltd., has been established with a registered capital of 15 million yuan, focusing on artificial intelligence resources and technology platform development [7] - The company is jointly owned by Anhui Xunfei Cloud Creation Technology Co., Ltd., Jiuchuan Technology (Ningxia) Co., Ltd., and Yinchuan Innovation Development Investment Group Co., Ltd. [7]

Performance Forecast - The company expects a net profit attributable to shareholders of between 125 million and 156 million yuan, representing a year-on-year increase of 60.52% to 100.33% compared to 77.87 million yuan in the same period last year [1] - The net profit after deducting non-recurring gains and losses is projected to be between 67 million and 88 million yuan, showing a year-on-year increase of 3.58% to 36.05% compared to 64.68 million yuan last year [1] - Basic earnings per share are estimated to be between 0.1260 yuan and 0.1573 yuan, compared to 0.0781 yuan in the previous year [1] Reasons for Performance Change - The company has achieved a record high in net profit for the half-year period, with a year-on-year increase of 60% to 100%, and a more than 50% increase in net profit for the second quarter alone [1] - The recent launch of AI smart home care services has created a synergistic ecosystem, enhancing the company's growth potential through deep integration of technology and scenarios in the smart elderly care service system [1] - The ongoing strategy of integrating education and industry has expanded the company's training scale, contributing to talent development and innovation, which in turn has improved overall operational efficiency and significantly reduced expense ratios [1]

Group 1: Company Announcements - Changchun High-tech plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its global strategy and international brand image [1] - Saisir reported June sales of 46,086 new energy vehicles, a year-on-year increase of 4.44%, with a total of 172,100 units sold in the first half of the year, down 14.35% year-on-year [1] - Hangzhou High-tech announced a change in controlling shareholder to Jirong Weiye, with stock resuming trading on July 2, 2025 [1] Group 2: Financial Performance - Guomai Technology expects a net profit of 125 million to 156 million yuan for the first half of 2025, a year-on-year increase of 60.52% to 100.33% [2] - Kid King anticipates a net profit of 120 million to 160 million yuan for the first half of 2025, representing a year-on-year growth of 50% to 100% [2] - Mould Technology received a project from a well-known North American electric vehicle company, with expected total sales of 1.236 billion yuan over five years [3] Group 3: Regulatory and Compliance - *ST Yuancheng is under investigation by the China Securities Regulatory Commission for suspected false disclosures in financial reports [4] - The company received a notice of investigation on July 1, 2025, which may lead to significant penalties and potential delisting [4] Group 4: Market Activity - Changcheng Military Industry's stock has experienced significant volatility, with a cumulative price deviation exceeding 20% over three trading days, indicating potential irrational speculation [5] - Anglikang has only one innovative drug project, ALK-N001, currently in Phase I clinical trials, highlighting the long and uncertain nature of drug development [6] Group 5: Sales and Contracts - Beiqi Blue Valley's subsidiary reported a 139.73% year-on-year increase in sales for the first half of the year [7] - Dong'an Power's engine sales in June increased by 82.79% year-on-year [7] - Pudong Construction's subsidiary won multiple major projects with a total bid amount of 1.964 billion yuan [7]

Group 1 - TaiLong Pharmaceutical plans to apply for the registration and issuance of super short-term financing bonds not exceeding 800 million yuan, with a maturity of no more than 270 days, for purposes including replacing bank loans and supplementing working capital [1] - GuoXin Technology won a bid for a 46 million yuan automotive airbag ignition driver chip project, indicating its growing presence in the automotive semiconductor market [1] - GuoMai Technology expects a net profit increase of 60.52% to 100.33% for the first half of 2025, with a projected net profit of 125 million to 156 million yuan [2] Group 2 - ChangAluminum's subsidiary signed a 165 million yuan contract for the customized construction of a clinical and industrial base for a vaccine project, highlighting its involvement in the biopharmaceutical sector [3] - ZhongSalt Chemical acquired exploration rights for natural soda ash in Inner Mongolia for 929,000 yuan, expanding its resource base [4] - Six Kingdom Chemical announced the resignation of its deputy general manager, which may impact its operational strategy [5][6] Group 3 - FuYuan Pharmaceutical received a drug registration certificate for Bisoprolol Amlodipine tablets, indicating its expansion in the hypertension treatment market [7][8] - GuanShi Technology's subsidiary received a government subsidy of 7 million yuan, which is 45.29% of its net profit for the previous year, enhancing its financial position [9] - XiZhong Technology plans to repurchase shares worth between 75 million and 150 million yuan, aimed at employee stock ownership plans or equity incentives [10] Group 4 - BeiLu Pharmaceutical's subsidiary received approval for the raw material drug Iopromide, which is used as a contrast agent for various imaging examinations [12] - HongHui New Materials obtained a patent for a water-based protective paint for hardware parts, enhancing its product portfolio [13] - BoJi Pharmaceutical's subsidiary received two patents related to high bioavailability formulations, indicating innovation in biopharmaceutical technology [14] Group 5 - ChengJian Development received a cash dividend of 23.625 million yuan from its investment in Huaneng Capital, contributing to its investment income [15] - JiuZhou Pharmaceutical's subsidiary received a drug registration certificate for Sildenafil Citrate orally disintegrating tablets, expanding its product offerings in the erectile dysfunction treatment market [16] - RuiAng Gene's subsidiary received a government subsidy of 176,290 yuan, supporting its operational activities [17] Group 6 - FengFan Technology plans to acquire 100% equity of a subsidiary for 48 million yuan, indicating strategic expansion in the renewable energy sector [18] - AoJing Medical's subsidiary received a medical device production license, allowing it to manufacture absorbable surgical dressings [19] - TaiLin Bio's subsidiary won land use rights for an industrial site, facilitating its high-performance filter project [20] Group 7 - KaiPu Bio received a patent for a method and device for analyzing genomic copy number variations, enhancing its capabilities in molecular diagnostics [21] - Shanghai KaiBao received a drug registration certificate for Phlegm-Heat Clearing Capsules, which can be used in the treatment of COVID-19 symptoms [23] - TuoJing Life received two patents for high uniformity streptavidin applications, improving its diagnostic product stability [25] Group 8 - AnKe Bio's AK2024 injection received approval for clinical trials, marking a significant advancement in cancer treatment [26] - HuanYuan Pharmaceutical expects a net profit of 142 million to 160 million yuan for the first half of 2025, reflecting substantial growth [27] - JinHongShun terminated a major asset restructuring plan due to a lack of consensus among parties involved, impacting its strategic direction [28] Group 9 - HeZhan Energy signed a 177 million yuan contract for the sale of steel-concrete tower structures, indicating strong demand in the renewable energy sector [29] - InSai Group's acquisition plan for an 80% stake in ZhiZheTongXing was accepted by the Shenzhen Stock Exchange, indicating growth in its consulting business [30] - JiuDian Pharmaceutical received a drug registration certificate for Zinc Granules, enhancing its product line in gastrointestinal treatments [32] Group 10 - GuoYao Modern plans to publicly transfer a 51% stake in its subsidiary to optimize resource allocation [34] - GuoYao Modern's subsidiary received a drug registration certificate for Perindopril Indapamide tablets, expanding its hypertension treatment portfolio [36] - ZhongGong International signed a 175 million yuan engineering consulting service contract, showcasing its capabilities in project management [38] Group 11 - China Railway won contracts worth approximately 5.343 billion yuan for overseas construction projects, indicating its strong international presence [39] - JunPu Intelligent signed a framework contract for humanoid robot sales worth about 28.25 million yuan, reflecting growth in the robotics sector [41] - Sinopec's chairman resigned due to age, which may lead to changes in corporate governance [42] Group 12 - JiuFeng Energy's controlling shareholder plans to reduce their stake by up to 0.71%, indicating potential changes in ownership structure [44] - Zhejiang Oriental's subsidiary plans to establish a 1.74 billion yuan equity investment fund, focusing on strategic emerging industries [46] - ChenGuang New Materials received a government subsidy of 26 million yuan, significantly impacting its financial performance [48]

Core Viewpoint - Guomai Technology (国脉科技) is experiencing significant growth in its financial performance, with projections indicating a substantial increase in net profit and revenue, driven by innovative business models and strategic investments in technology and education [2][3][4]. Financial Performance - For the first half of 2025, the company expects a net profit attributable to shareholders of between 125 million yuan and 156 million yuan, representing a year-on-year growth of 60.52% to 100.33% [2]. - The non-recurring net profit is projected to be between 67 million yuan and 88 million yuan, showing a growth of 3.58% to 36.05% compared to the previous year [2]. - In 2024, the total operating revenue reached 549 million yuan, marking a six-year high, with a net profit of 169 million yuan, up 61.41% year-on-year, achieving a historical peak [2]. Business Development - The company is focusing on deep integration of industry and education, which has led to a decrease in total expenses by 31.02% while maintaining revenue growth [2]. - The asset quality has improved, with a cash-rich position and a low debt ratio of 15.63%, and zero interest-bearing debt [2]. Innovation and Strategic Initiatives - The company has launched the first domestic AI smart agent for home-based elderly care, which is expected to enhance the smart transformation of elderly services [4]. - The AI smart agent is designed to be a specialized tool for home care and health management, differentiating itself from generic models by addressing specific user needs and integrating offline services [4][5]. - The "Guomai University Elderly Care" initiative provides a practical application and data feedback for the AI smart agent, facilitating product performance validation and optimization [5]. Market Engagement - Since May, the company has attracted significant attention from institutional investors, indicating growing interest in its innovative approaches and market potential [4].

1．业绩预告期间：2025 年 1 月 1 日至 2025 年 6 月 30 日 2.预计的经营业绩：同向上升 | 项 目 | 本报告期 | | 上年同期 | | --- | --- | --- | --- | | 归属于上市公司 | 盈利：12,500 万元 | 万元-15,600 | 盈利：7,787.31 万元 | | 股东的净利润 | 比上年同期增长：60.52%-100.33% | | | | 扣除非经常性损 | 盈利：6,700 万元 | 万元-8,800 | 盈利：6,468.23 万元 | | 益后的净利润 | 比上年同期增长：3.58%-36.05% | | | | 基本每股收益 | 盈利：0.1260 元/股 | 元/股-0.1573 | 盈利：0.0781 元/股 | 二、与会计师事务所沟通情况 业绩预告为公司计划财务部初步核算数据，未经过注册会计师预审计。 证券代码：002093 证券简称：国脉科技 公告编号：2025—033 2025 年半年度业绩预告 国脉科技股份有限公司 公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、本期业绩预 ...

国脉科技（002093）公告，预计2025年上半年净利润为1.25亿元-1.56亿元，比上年同期的7787.31万元 增长60.52%-100.33%。 ...